English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/24128
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels

AuthorsGenaro, Ana M.; Hortelano, Sonsoles; Álvarez, Alberto; Martínez-Alonso, Carlos; Boscá, Lisardo
KeywordsNitric oxide
B cells
Issue DateApr-1995
PublisherAmerican Society for Clinical Investigation
CitationJournal of Clinical Investigation 95(4): 1884-1890 (1995)
AbstractIncubation of ex vivo cultured mature B cells in the presence of nitric oxide or nitric oxide-donor substances delays programmed cell death as determined by the appearance of DNA laddering in agarose gel electrophoresis or by flow-cytometry analysis of DNA. Nitric oxide also rescues B cells from antigen-induced apoptosis but fails to provide a co-stimulatory signal that converts the signal elicited by the antigen into a proliferative response. The protective effects of nitric oxide against programmed cell death can be reproduced by treatment of the cells with permeant analogues of cyclic GMP. Regarding the mechanisms by which nitric oxide prevents apoptosis in B cells, we have observed that nitric oxide release prevents the drop in the expression of the protooncogene bcl-2, both at the mRNA and protein levels, suggesting the existence of an unknown pathway that links nitric oxide signaling with Bcl-2 expression.
Description7 pages, 6 figures, 2 tables.
Publisher version (URL)http://dx.doi.org/10.1172/JCI117869
Appears in Collections:(IIBM) Artículos
Files in This Item:
File Description SizeFormat 
Splenic B.pdf1,58 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.